Rheumatology

This Janssen-sponsored live symposium “Advancing the Treatment of PsA: Focus on the IL-23 Pathway,” took place virtually at the European League Against…

Prof Schett opened the session by explaining the overall theme and objectives of the symposium. Charles Darwin famously visited the Galápagos islands…

Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated arthritis characterised by joint inflammation and diverse clinical manifestations…

Clinical Prof Daniel Wallace   |  Rheumatologist, Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center, Los Angeles,  California, USA…

Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…

Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.

Rheumatoid arthritis (RA) is associated with changes in skeletal health, including increased risk of fracture.

The purpose of this review is to provide a clinically focussed description of the relevant aetiopathogenesis, clinical expression of disease, approach to the assessment and treatment of Systemic Sclerosis, and highlight the recent advances and future challenges associated with this complex disease.